亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study

医学 肝细胞癌 内科学 临床试验 肿瘤科 切除术 2型糖尿病 糖尿病 前瞻性队列研究 药方 外科 胃肠病学 总体生存率 癌 肝切除术 子群分析 生存分析 病历 荟萃分析 无进展生存期 存活率 随机对照试验 受体
作者
Yan‐Jun Xiang,Zong‐Han Liu,Jin-Kai Feng,Yingyi Qin,Hongming Yu,Yuqiang Cheng,Gang Chen,Jiayi Wu,Tingfeng Huang,Y C Tang,Jianhua Rao,Feng‐Min Zhang,Shiye Yang,Wang Gui-ran,Linsen Ye,Ren Lang,Jian-hua Lin,Yi-Tao Zheng,Ye-Fan Mao,Hong-Kun Zhou
出处
期刊:Gut [BMJ]
卷期号:: gutjnl-2026 被引量:3
标识
DOI:10.1136/gutjnl-2026-338462
摘要

BACKGROUND: Recurrence after curative-intent resection remains common in hepatocellular carcinoma (HCC), and whether postoperative incretin-based treatment choice influences outcomes in patients with type 2 diabetes (T2D) is unclear. OBJECTIVE: To determine whether postoperative initiation of glucagon-like peptide-1 receptor agonists (GLP-1RAs), compared with dipeptidyl peptidase-4 inhibitors (DPP-4is), is associated with improved recurrence-free and overall survival after curative-intent resection for HCC. DESIGN: Active-comparator, new-user target trial emulation using electronic medical records from 36 hospitals across China from 2014 to 2023, with follow-up through 1 October 2025. Eligible adults had histologically confirmed HCC and T2D, underwent R0 resection and initiated a GLP-1RA or DPP-4i within postoperative days 0 to 90. Time zero was the first qualifying prescription or order date. The primary estimand was intention-to-treat; a prespecified per-protocol analysis assessed sustained adherence. The primary outcome was recurrence-free survival (RFS), treating death without recurrence as a competing event; overall survival (OS) was secondary. The study was registered with the Chinese Clinical Trial Registry (ChiCTR2600118495). RESULTS: Among 42 855 patients with HCC and T2D who underwent liver resection, 1249 were included in the final analytical cohort, including 723 DPP-4i initiators and 526 GLP-1RA initiators; median follow-up was 50.8 months. In weighted intention-to-treat analyses, GLP-1RA versus DPP-4i initiation was associated with longer RFS (cause-specific HR 0.80, 95% CI 0.67 to 0.96; p=0.016) and OS (HR 0.58, 95% CI 0.47 to 0.71; p<0.001). Per-protocol analyses were directionally consistent. CONCLUSION: Postoperative GLP-1RA initiation, compared with DPP-4i initiation, was associated with delayed recurrence and longer OS; prospective confirmation is warranted. TRIAL REGISTRATION NUMBER: ChiCTR2600118495.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
斯文败类的应助被纯情的阁采纳,获得10
4秒前
科研通AI6.3的应助被纯情的阁采纳,获得10
4秒前
真的不会完成签到,获得积分10
4秒前
笙笙的应助被纯情的阁采纳,获得10
4秒前
科研通AI6.3的应助被纯情的阁采纳,获得10
4秒前
4秒前
KKIII发布了新的文献求助10
7秒前
雉鸥完成签到 ,获得积分10
7秒前
Ming完成签到 ,获得积分10
8秒前
Richard完成签到,获得积分10
11秒前
14秒前
香蕉觅云的应助被纯情的阁采纳,获得30
14秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
15秒前
科研通AI6.3的应助被纯情的阁采纳,获得10
15秒前
科研通AI6.3的应助被纯情的阁采纳,获得10
15秒前
笙笙的应助被纯情的阁采纳,获得10
15秒前
王占雪完成签到 ,获得积分10
15秒前
Maestro_S的应助被纯情的阁采纳,获得30
15秒前
顺利夏云完成签到,获得积分10
20秒前
only完成签到 ,获得积分10
26秒前
英俊的未来完成签到 ,获得积分10
28秒前
29秒前
年轻靖巧完成签到,获得积分10
29秒前
32秒前
xl的应助被科研通管家采纳,获得10
33秒前
33秒前
33秒前
ldxghh发布了新的文献求助10
33秒前
34秒前
34秒前
34秒前
34秒前
脑洞疼的应助被2589采纳,获得10
40秒前
45秒前
欣喜香菇发布了新的文献求助10
50秒前
坦率黑米完成签到,获得积分10
50秒前
reece完成签到 ,获得积分10
50秒前
科研通AI6.4的应助被KKIII采纳,获得10
50秒前
芜湖发布了新的文献求助10
53秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565447
关于积分的说明 21780029
捐赠科研通 7764817
什么是DOI,文献DOI怎么找? 3431496
关于科研通互助平台的介绍 2555519
邀请新用户注册赠送积分活动 2476571